MGTX Company Profile and Key Details

Q: Who are the executives of MGTX?

Mr. Robert J. Wollin J.D.Gen. Counsel & Sec.Dr. Alexandria ForbesChief Executive Officer, Pres & DirectorDr. Stuart Naylor Ph.D.Chief Devel. OfficerMr. Tim RandallSenior Vice President of Risk & Internal ControlsMr. Richard Brian Giroux B.A.Chief Operating Officer & Chief Financial OfficerDr. Alastair Leighton Ph.D.Senior Vice President of Manufacturing & Supply ChainDr. Robert K. Zeldin M.D.Chief Medical OfficerDr. Michel Michaelides M.D.Head of Clinical OphthalmologyDr. Alexandria Forbes Ph.D.Chief Executive Officer, Pres & DirectorMr. Joel P. BrooksSenior Vice President of Fin.

NASDAQ : MGTX

MeiraGTx

$7.84

0.47+6.38%

Open: 12:18 PM

60.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MeiraGTx Holdings plc (MGTX) stock surged +6.38%, trading at $7.84 on NASDAQ, up from the previous close of $7.37. The stock opened at $7.46, fluctuating between $7.46 and $7.92 in the recent session.

Stock Snapshot

7.37

Prev. Close

631.05M

Market Cap

7.46

Day Low

-3.72

P/E Ratio

-2.11

EPS (TTM)

-1.97

Cash Flow per Share

7.46

Open

80.49M

Number of Shares

7.92

Day High

77.12%

Free Float in %

2.17

Book Value

581.83K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 09, 2026	6.95	7.39	6.89	7.37	461.82K
Mar 06, 2026	6.81	7.07	6.80	7.00	308.81K
Mar 03, 2026	7.38	7.58	7.25	7.43	230.22K
Mar 02, 2026	7.33	7.63	7.26	7.58	317.67K
Feb 27, 2026	7.58	7.69	7.48	7.56	188.88K
Feb 26, 2026	7.81	7.84	7.49	7.66	226.52K
Feb 25, 2026	7.71	7.96	7.64	7.84	265.97K
Feb 24, 2026	7.58	7.90	7.57	7.70	328.01K
Feb 23, 2026	7.45	7.70	7.45	7.54	293.59K
Feb 20, 2026	7.44	7.57	7.31	7.45	301.82K
Feb 19, 2026	7.47	7.66	7.42	7.54	227.32K
Feb 18, 2026	7.60	7.74	7.47	7.51	405.21K
Feb 17, 2026	7.50	7.75	7.44	7.58	201.38K
Feb 13, 2026	7.48	7.70	7.26	7.45	235.51K
Feb 12, 2026	7.50	7.64	7.16	7.36	352.24K
Feb 11, 2026	7.53	7.63	7.30	7.46	296.37K
Feb 10, 2026	7.61	7.63	7.49	7.52	250.03K
Feb 09, 2026	7.42	7.70	7.22	7.63	284.55K
Feb 06, 2026	7.34	7.57	7.22	7.43	613.71K
Feb 05, 2026	7.66	7.85	7.17	7.20	472.72K

Contact Details

New York City, NY 10016

United States

https://www.meiragtx.com 646 860 7985

About Company

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Stock Peers

REGN

21.74+2.86%

Regeneron Pharmaceuticals, Inc.$781.60 ARGX

22.6+3.15%

argenx SE$740.40 UTHR

51.01+10.67%

United Therapeutics Corporation$529.17 VRTX

4.18+0.92%

Vertex Pharmaceuticals Incorporated$460.87 MDGL

0.37+0.09%

Madrigal Pharmaceuticals, Inc.$433.20 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

2.93+0.91%

Alnylam Pharmaceuticals, Inc.$323.59 PRAX

-1.7-0.55%

Praxis Precision Medicines, Inc.$309.01 KRYS

4.96+1.96%

Krystal Biotech, Inc.$258.65 ASND

-0.73-0.30%

Ascendis Pharma A/S$239.92

Company Overview

MeiraGTx Holdings plc (NASDAQ:MGTX) closed at $7.84 USD, gaining $0.47 (6.38%) from the previous close of $7.37. The stock is currently mid-range between its 52-week high and low $4.55 and $9.73. With a market capitalization of about $631.05 million, MeiraGTx Holdings plc is classified as a small-cap and shows higher-than-market volatility (beta ~1.40). Key stats such as the average daily volume over the past year has been around 413.47 thousand shares, in line with its 52-week average. Headquartered in New York City, NY, MeiraGTx Holdings plc operates in the Healthcare sector and the Biotechnology industry. Led by CEO Alexandria Forbes, the company employs approximately 375 people and listed since June 08, 2018. MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases.

Technical Performance

MGTX has shown mixed momentum, gaining 1.1% over the past week and -5.55% over the past quarter, though year-to-date performance is down -7.92%. Short-term trend indicators are mixed aligned (SMA20 0.88%, SMA50 -1.06%, SMA200 0.42%). The stock’s 14-day RSI is 50.36 (neutral), while the ATR of 0.37 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -21.27% below its high and over 68.35% above its low. Average 10-day trading volume of 329.63 thousand shares is below the 3-month average of 391.59 thousand, indicating normal recent market interest.

Valuation Metrics

MeiraGTx Holdings plc trades at a P/E ratio of -3.46, slightly below the S&P 500 average, with a price-to-sales ratio of 21.2 and a price-to-book ratio of -14.41 indicating negative book value, which may reflect financial stress. The P/FCF stands at -4.8, also above market averages.

Dividend & Fair Value

MeiraGTx Holdings plc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$5.82. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

MeiraGTx Holdings plc generated EPS of -$2.11 over the past year. Five-year average earnings growth is -5.1%. Wall Street analysts project EPS growth of 27.24% annually over the next five years. The latest quarter delivered EPS of -$0.62. The next quarter is forecast at -$0.57. Next year's EPS is expected at $31.30. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $35.00 to $13.00. The high target offers 374.9% upside. The low target suggests 76.39% downside. The mean target is $26.62. This offers 261.19% upside. MeiraGTx Holdings plc earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 13, 2025, missed forecasts by 24.0%. The prior quarter beat by -7.69%. Over the last six quarters, Apple has recorded several small beats. These include 145.16% in August 12, 2024.

Shareholding & Insider Activity

MeiraGTx Holdings plc has 80.45 million shares outstanding. The public float is 31.70 million shares, elevated short interest at 6.37% of float. This equals 3.30 million shares. The short ratio is 4.92 days. Institutional investors hold 85.67% of the float. Insiders own 24.15%. PERCEPTIVE ADVISORS LLC holds 12.53 million shares, PERCEPTIVE LIFE SCIENCES MASTER FUND LTD has 6.01 million shares and Forbes Alexandria has 1.31 million shares. Over the past six months, insider transactions show net selling. They sold 71.50 thousand shares across 2 transactions.

Financial & Profitability Overview

Over the trailing twelve months, MeiraGTx generated $14.02M in revenue, or $0.25 per share. Gross margin was 2.05%, operating margin -977.82%, and net profit margin -599.46%. Returns are negative, with ROA at -18.34% and ROE at -60.81%.
On valuation metrics, MeiraGTx trades at a P/E of -3.46, P/S of 21.20 and P/B of -14.41. Liquidity is tight, with a current ratio of 0.22 and quick ratio of 0.22. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -328.83 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is -2.17, supported by a cash flow-to-debt ratio of -1.32.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, MeiraGTx posted revenue of $14.02M, down slightly from $15.92M in the prior quarter. Gross profit was $287.00K (margin 2.05%). Operating income was - $137.06M (margin -977.8%). Net income was- $84.03M (EPS - $1.49).
The company ended the quarter with $129.57M in cash and short-term investments, a total debt of $89.26M, and net debt of - $40.30M. Total assets were $458.17M, with equity of $138.18M. Financials further reflected weakness, with operating cash flow of - $105.37M, free cash flow of - $125.54M, and capital expenditures of - $20.17M.

Price Forecast & Outlook

Our AI price prediction model suggests that MeiraGTx Holdings plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.17%, with price expected at $7.21 by March 23, 2026, within a range of $6.91 to $7.49 3-Month Outlook: Projected fall of -28.09%, reaching $5.30 by June 05, 2026, with a range of $5.13 to $5.45. 1-Year Outlook: Projected gain of 245.18%, with price at $25.44 by March 09, 2027, within a range of $20.72 to $34.13.

Key Takeaways

MeiraGTx Holdings plc (NASDAQ:MGTX) shares are flat -7.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows MeiraGTx Holdings plc trading at a premium to the broader market with a P/E of -3.46. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $29.30, suggesting 297.56% upside. Our AI forecast model points to short-term weakness (-2.17% over two weeks), a medium-term fall (-28.09% over three months), and a longer-term gain (245.18% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current MeiraGTx Holdings plc (MGTX) stock price?

MeiraGTx Holdings plc (NASDAQ: MGTX) stock price is $7.84 in the last trading session. During the trading session, MGTX stock reached the peak price of $7.92 while $7.46 was the lowest point it dropped to. The percentage change in MGTX stock occurred in the recent session was 6.38% while the dollar amount for the price change in MGTX stock was $0.47.

MGTX's industry and sector of operation?

The NASDAQ listed MGTX is part of Biotechnology industry that operates in the broader Healthcare sector. MeiraGTx Holdings plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MGTX?

Mr. Robert J. Wollin J.D.
Gen. Counsel & Sec.
Dr. Alexandria Forbes
Chief Executive Officer, Pres & Director
Dr. Stuart Naylor Ph.D.
Chief Devel. Officer
Mr. Tim Randall
Senior Vice President of Risk & Internal Controls
Mr. Richard Brian Giroux B.A.
Chief Operating Officer & Chief Financial Officer
Dr. Alastair Leighton Ph.D.
Senior Vice President of Manufacturing & Supply Chain
Dr. Robert K. Zeldin M.D.
Chief Medical Officer
Dr. Michel Michaelides M.D.
Head of Clinical Ophthalmology
Dr. Alexandria Forbes Ph.D.
Chief Executive Officer, Pres & Director
Mr. Joel P. Brooks
Senior Vice President of Fin.

How MGTX did perform over past 52-week?

MGTX's closing price is 61.98% higher than its 52-week low of $4.55 where as its distance from 52-week high of $9.73 is -24.25%.

How many employees does MGTX have?

Number of MGTX employees currently stands at 375.

Link for MGTX official website?

Official Website of MGTX is: https://www.meiragtx.com

How do I contact MGTX?

MGTX could be contacted at phone 646 860 7985 and can also be accessed through its website. MGTX operates from 430 East 29th Street, New York City, NY 10016, United States.

How many shares of MGTX are traded daily?

MGTX stock volume for the day was 581.83K shares. The average number of MGTX shares traded daily for last 3 months was 413.47K.

What is the market cap of MGTX currently?

The market value of MGTX currently stands at $631.05M with its latest stock price at $7.84 and 80.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	375
Beta	1.4
Sales or Revenue	$14.02M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MGTX Company Profile and Key Details

MeiraGTx

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways